These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30815698)

  • 21. Immediate recovery of acquired von Willebrand syndrome after left ventricular assist device explantation: implications for heart transplantation.
    Davis ME; Haglund NA; Tricarico NM; Matafonov A; Gailani D; Maltais S
    ASAIO J; 2015; 61(1):e1-4. PubMed ID: 25251586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependent.
    Jilma-Stohlawetz P; Quehenberger P; Schima H; Stoiber M; Knöbl P; Steinlechner B; Felli A; Jilma B
    Thromb Res; 2016 Jan; 137():196-201. PubMed ID: 26616301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.
    Meyer AL; Malehsa D; Bara C; Budde U; Slaughter MS; Haverich A; Strueber M
    Circ Heart Fail; 2010 Nov; 3(6):675-81. PubMed ID: 20739614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Molecular Weight von Willebrand Factor Multimer Loss and Bleeding in Patients with Short-Term Mechanical Circulatory Support Devices: A Case Series.
    Goldfarb M; Czer LS; Lam LD; Moriguchi J; Arabia FA; Volod O
    J Extra Corpor Technol; 2018 Jun; 50(2):77-82. PubMed ID: 29921985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of inhibitors in acquired von Willebrand syndrome.
    Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
    Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of HeartWare ventricular assist device on the von Willebrand factor: results of an academic Belgian center.
    Esmaeilzadeh F; Wauters A; Wijns W; Argacha JF; van de Borne P
    BMC Cardiovasc Disord; 2016 Aug; 16(1):155. PubMed ID: 27485105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired von Willebrand Syndrome: An Under-Recognized Cause of Major Bleeding in the Cardiac Intensive Care Unit.
    Jones MB; Ramakrishnan K; Alfares FA; Endicott KM; Oldenburg G; Berger JT; Shankar V; Nath DS; Diab YA
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):711-716. PubMed ID: 27834763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients.
    Crow S; Chen D; Milano C; Thomas W; Joyce L; Piacentino V; Sharma R; Wu J; Arepally G; Bowles D; Rogers J; Villamizar-Ortiz N
    Ann Thorac Surg; 2010 Oct; 90(4):1263-9; discussion 1269. PubMed ID: 20868825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet dysfunction and acquired von Willebrand syndrome in patients with left ventricular assist devices.
    Baghai M; Heilmann C; Beyersdorf F; Nakamura L; Geisen U; Olschewski M; Zieger B
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):421-7. PubMed ID: 25543177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.
    Deconinck S; Tersteeg C; Bailleul E; Delrue L; Vandeputte N; Pareyn I; Itzhar-Baikian N; Deckmyn H; De Meyer SF; Vanderheyden M; Vanhoorelbeke K
    Res Pract Thromb Haemost; 2018 Oct; 2(4):762-766. PubMed ID: 30397685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stress and Exposure Time on von Willebrand Factor Degradation.
    Jhun CS; Siedlecki C; Xu L; Lukic B; Newswanger R; Yeager E; Reibson J; Cysyk J; Weiss W; Rosenberg G
    Artif Organs; 2019 Feb; 43(2):199-206. PubMed ID: 30374981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual Variability in von Willebrand Factor Fragility in Response to Shear Stress: A Possible Clue for Predicting Bleeding Risk.
    Sakatsume K; Akiyama M; Sakota D; Hijikata W; Horiuchi H; Maruyama O; Saiki Y
    ASAIO J; 2022 Sep; 68(9):1128-1134. PubMed ID: 34967782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired von Willebrand syndrome associated with left ventricular assist device.
    Nascimbene A; Neelamegham S; Frazier OH; Moake JL; Dong JF
    Blood; 2016 Jun; 127(25):3133-41. PubMed ID: 27143258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mathematical model for assessing shear induced bleeding risk.
    Li Y; Wang H; Xi Y; Sun A; Wang L; Deng X; Chen Z; Fan Y
    Comput Methods Programs Biomed; 2023 Apr; 231():107390. PubMed ID: 36745955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis.
    Rauch A; Caron C; Vincent F; Jeanpierre E; Ternisien C; Boisseau P; Zawadzki C; Fressinaud E; Borel-Derlon A; Hermoire S; Paris C; Lavenu-Bombled C; Veyradier A; Ung A; Vincentelli A; van Belle E; Lenting PJ; Goudemand J; Susen S
    Thromb Haemost; 2016 May; 115(5):950-9. PubMed ID: 26791163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward a Standard Practice to Quantify von Willebrand Factor Degradation During Left Ventricular Assist Device Support.
    Hennessy-Strahs S; Bermudez CA; Acker MA; Bartoli CR
    Ann Thorac Surg; 2021 Oct; 112(4):1257-1264. PubMed ID: 33227272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left Ventricular Assist Device Design Reduces von Willebrand Factor Degradation: A Comparative Study Between the HeartMate II and the EVAHEART Left Ventricular Assist System.
    Bartoli CR; Kang J; Zhang D; Howard J; Acker M; Atluri P; Motomura T
    Ann Thorac Surg; 2017 Apr; 103(4):1239-1244. PubMed ID: 27717422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of von Willebrand factor multimer abnormalities before and after aortic valve replacement using the Hydragel-5 assay.
    Hamiko M; Gerdes L; Silaschi M; Seidel H; Westhofen P; Kruppenbacher J; Hertfelder HJ; Oldenburg J; Bakhtiary F; Velten M; Oezkur M; Duerr GD
    Thromb Res; 2024 Sep; 241():109094. PubMed ID: 38991494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation.
    Deconinck SJ; Nix C; Barth S; Bennek-Schöpping E; Rauch A; Schelpe AS; Roose E; Feys HB; Pareyn I; Vandenbulcke A; Muia J; Vandenbriele C; Susen S; Meyns B; Tersteeg C; Jacobs S; De Meyer SF; Vanhoorelbeke K
    J Thromb Haemost; 2022 Dec; 20(12):2797-2809. PubMed ID: 36128768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
    Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
    J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.